Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter s Q1 Revenue Slides 1 Percent as Profit Jumps 27 Percent

NEW YORK, May 3 (GenomeWeb News) - Beckman Coulter today said revenues for the first quarter dipped slightly, while net income grew by over a quarter.


Beckman posted $560 million in revenues for the quarter ended March 31, a 1.2 percent decline from the $576 million the company earned in the same period of last year. The company attributed the decline to a change in instrument leasing policy.


Beckman said that it spent $55 million on R&D in the first quarter, compared to $48 million in the comparable period last year.


Net income for the quarter grew 27 percent to $41.4 million from $32.6 million in the year-ago period.


As of March 31, Beckman had $59 million in cash and cash equivalents.


Beckman said it expects second-quarter revenue to be between $620 million and $645 million, which would be improvements of between .3 percent and 4.4 percent above the $618.8 million the company posted for the second quarter last year.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.